Table 2.
HDV and HBV transplants performed in Torino from 2000 to 2019.
| 2000–2009 |
2010–2019 |
|||||
|---|---|---|---|---|---|---|
| Overall | HDV positive | HBV monoinfected | Overall | HDV positive | HBV monoinfected | |
| LT, N (%) | 361 | 139 (38.5%) | 222 (61.5%) | 259 | 130 (50.2%) | 129 (49.8%) |
| Age (years), median (95% CI) | 52.8 (51.9–54.1) | 48.6 (46.6–50.7) | 55.3 (54.2–56.1) | 56.7 (55.6–57.2) | 54.3 (52.3–55.7) | 58.0 (57.1–59.8) |
| Gender, M/F | 303/58 | 102/37 | 201/21 | 211/48 | 95/35 | 116/13 |
| Indication for transplantation: | ||||||
| HCC | 29/139 (20.9%) | 121/222 (54.5%) | 49/130 (37.7%) | 91/129 (70.5%) | ||
| Liver failure | 110/139 (79.1%) | 101/222 (45.5%) | 81/130 (62.3%) | 38/129 (29.5%) |
Abbreviations: CI, confidence interval; HCC, hepatocellular carcinoma; N, number; M/F, male to female ratio; LT, liver transplantation.